Return to homepagePandemic Pact

Nanoparticle-based vaccine / SARS-CoV-2

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    ANR

  • Principal Investigator

    Isabelle DIMIERPOISSON

  • Research Location

    France

  • Lead Research Institution

    Université de Tours

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The NANO-SARS-CoV-2 project, coordinated by Isabelle Dimier-Poisson (UMR 1282 - INRAE - University of Tours), concerns the development of an anti-SARS-CoV-2 vaccine platform made up of biocompatible nanoparticles encapsulating the antigenic candidates S and N of SARS-CoV-2, or associating viral-like particles (VLP) of SARS-CoV-2, in order to induce humoral and cellular immune responses at the level of the mucosal and systemic compartments. It aims to deliver a nanoparticulate mucosal vaccine candidate against SARS-CoV-2.